...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Impact of news
8
Feb 05, 2020 03:44PM
1
Feb 05, 2020 03:49PM
5
Feb 05, 2020 07:22PM
1
Feb 05, 2020 07:34PM
7
Feb 05, 2020 07:55PM
4
Feb 05, 2020 08:14PM
2
Feb 05, 2020 09:10PM

For what it's worth, my opinion is that any BP that buys RVX will need to have three things: 1. An existing interest in genetics (e.g., gene therapy, gene editing). 2. A presence in the fields of diabetes, kidney disease, and cardiovascular disease. 3. The pockets to fund whatever it is the FDA is recommending to push RVX-208 over the line. There must be several out there.

 

 

 

 

 

 

 

Share
New Message
Please login to post a reply